- Home
- TLRY
TLRY
Tilray Brands Inc.
as 07-26-2024 4:00pm EST
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Upcoming Earnings Alert:
Get ready for potential market movements as Tilray Brands Inc. TLRY prepares to release earnings report on 29 Jul 2024.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.5B | IPO Year: | 2018 |
| Target Price: | $2.25 | AVG Volume (30 days): | 15.2M |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.60 - $3.40 | Next Earning Date: | 07-29-2024 |
| Revenue: | $743,248,000 | Revenue Growth: | 24.65% |
| Revenue Growth (this year): | 27.27% | Revenue Growth (next year): | 11.31% |
Stock Insider Trading Activity of Tilray Brands Inc. (TLRY)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FALTISCHEK DENISE M | TLRY | Chief Strategy Officer | Jan 17 '24 | Buy | $2.05 | 10,000 | $20,500.00 | 293,269 | SEC Form 4 |
| Gendel Mitchell | TLRY | Global General Counsel | Jan 16 '24 | Buy | $1.98 | 7,200 | $14,256.00 | 195,796 | SEC Form 4 |
| SIMON IRWIN D | TLRY | President and CEO | Jan 12 '24 | Buy | $1.88 | 53,700 | $100,956.00 | 2,033,058 | SEC Form 4 |
| Gendel Mitchell | TLRY | Global General Counsel | Jan 12 '24 | Buy | $1.87 | 5,400 | $10,098.00 | 188,596 | SEC Form 4 |
| Merton Carl A | TLRY | Chief Financial Officer | Jan 12 '24 | Buy | $1.87 | 20,000 | $37,400.00 | 20,000 | SEC Form 4 |
Latest Tilray Brands Inc. News
TLRY Breaking Stock News: Dive into TLRY Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Tilray Brands Receives Approval for New Medical Cannabis Product in Portugal
Zacks
3 days ago
Tilray Brands (TLRY) Lined Up for Q4 Earnings: What Awaits?
MT Newswires
3 days ago
Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
Zacks
3 days ago
Tilray Brands, Inc. (TLRY) Suffers a Larger Drop Than the General Market: Key Insights
MT Newswires
5 days ago
Tilray's Aphria RX Granted New German Cannabis Cultivation License
MT Newswires
5 days ago
Tilray Up 2.8% In US Premarket As Says Received First New Cannabis Cultivation License in Germany Under New Regulations
GlobeNewswire
5 days ago
Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations
GlobeNewswire
8 days ago
SweetWater Brewing Launches New Rowdy Peach IPA in Collaboration With Atlanta United FC
Compare TLRY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLRY Tilray Brands Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.